Who are Nirsense's investors?

Nirsense's investors include Lighthouse Network Ventures Llc.

Where is Nirsense headquartered?

Nirsense is headquartered in Richmond, US.

Nirsense

Richmond, US · 1 known investors

Find your way into Nirsense

Paths you didn't know you had: your email and LinkedIn already hold routes to the Nirsense team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

NIRSense builds ruggedized, wireless hospital-quality patient monitors that measure tissue oxygen kinetics and other physiological data, including arterial (SpO2) and tissue (StO2) oxygenation, to help clinicians diagnose and treat critical conditions such as cardiogenic shock. Its devices are designed for use in uncontrolled environments including emergency and intensive care settings and military front lines.

Hardware Healthtech Medical Devices

Founders & leadership

Casey Boutwell Chief Executive OfficerCasey Boutwell is CEO of NIRSense, which develops wireless patient monitors for measuring tissue and arterial oxygenation in emergency and intensive care settings.

Josh AndrewsVP of Operations

Lori ParroCFO

Dan Rodenhaver Chief Commercial OfficerDan Rodenhaver founded Meru Biotechnologies, a biotech startup where he raised capital and managed technology development, and later established Forge Medical from inception to $5M in revenue across multiple product lines. He held senior commercial and operations roles at Stryker Craniomaxillofacial, driving significant regional growth, and currently serves as Chief Commercial Officer at NIRSense.

Investors · 1

Lighthouse Network Ventures Llclisted by Lighthouse Network Ventures LlcRichmond

How we know: Lighthouse Network Ventures Llc's portfolio page · Not right? Tell us

Related companies · 2

Senseonics HoldingsSenseonics develops and commercializes Eversense, an implantable continuous glucose monitoring system designed to measure blood sugar levels for up to one year in people with diabetes, offering an alternative to conventional glucose monitors that require more frequent sensor replacement. The company sells its system directly and through distribution partners in the United States and Europe.

ClearsenseClearsense operates the 1Clearsense Platform, a healthcare data lakehouse that unifies and manages disparate data for health systems and presents it in simplified, actionable views. The company targets health systems to reduce costs, improve operational efficiency, accelerate research and impact care outcomes.

Companies working in the same space as Nirsense.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
U.S. Air ForceAir Force	Phase II	2022	$1.5M
U.S. Air ForceAir Force	Phase ISTTR	2021	$50K
U.S. Air ForceAir Force	Phase I	2020	$50K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Nirsense do?: NIRSense builds ruggedized, wireless hospital-quality patient monitors that measure tissue oxygen kinetics and other physiological data, including arterial (SpO2) and tissue (StO2) oxygenation, to help clinicians diagnose and treat critical conditions such as cardiogenic shock. Its devices are designed for use in uncontrolled environments including emergency and intensive care settings and military front lines.
Who are Nirsense's investors?: Nirsense's investors include Lighthouse Network Ventures Llc.
Where is Nirsense headquartered?: Nirsense is headquartered in Richmond, US.